Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Nitric Oxide in Late Preterm Infants
NCT01748045Phase 3Terminated
- Sponsor
- Tufts Medical Center
- Start
- Mar 2013
- Primary completion
- Jul 2014
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 3 trial of nitric oxide in respiratory failure, bronchopulmonary dysplasia (BPD), sponsored by Tufts Medical Center. Started Mar 2013; status: terminated.
02
Drugs
nitric oxide
03
Conditions
respiratory failurebronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on NCT01748045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01748045.